Word: lowers
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...hastily assembled guerrillas. The only obvious difference now is that there are more Chechen fighters. Since the bloody debacle of 1994-'96, the Russian army's disintegration has continued. Budget cuts and corruption have undermined its strength and reduced training to a bare minimum, while morale has dropped even lower. But by some bizarre process of mental alchemy, the top Russian brass feels it can get it right this time...
...dollars they get as payment for goods and services and investing them in U.S. stocks and bonds. If the dollar continues to droop, they may be tempted to move their cash to currencies on the upswing, like the euro and, especially, the yen. That would drive the U.S. market lower. The more apocalyptic bears fear something worse. Because foreigners hold almost 40% of U.S. Treasury securities, any pullout would risk a spike in interest rates that would ultimately slaughter the bull market...
...trading partners of that, not to mention the government of Prime Minister Keizo Obuchi. Everyone, that is, except Masaru Hayami, chief of Japan's central bank, who late last month got into a public spat with Tokyo's powerful Ministry of Finance because the Bank of Japan refuses to lower interest rates or print money to bring the yen back to earth...
Even setting aside the hucksterism, laser surgery is hardly a risk-free procedure. Lasers work by emitting a powerful beam of light that vaporizes skin. Though some newer lasers can skip the top layer, or epidermis, penetrating to the lower dermis to kill abnormalities and hair follicles, lasers "wound" the skin to some degree, and healing can have complications. Long-term effects can include pigmentation changes in the skin: patients with darker complexions, such as African Americans or those of Mediterranean origin, are especially susceptible to skin lightening. And everyone is vulnerable to doctors or technicians who do not handle...
...houses in the U.S. and Europe, telling them that if they started making sulindac it would save thousands of lives. But it was about to come off patent, and as a generic drug it didn't offer much of a payoff because of the likelihood of competitive products and lower prices. Moreover, FAP--Nichols' cancer--is a so-called orphan disease, afflicting only 25,000 Americans, so there wasn't much of a market for it. Thanks, but no thanks, the drugmakers said...